PTRA Alpha and Beta Analysis
| PTRADelisted Stock | USD 1.54 0.04 2.53% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as PTRA. It also helps investors analyze the systematic and unsystematic risks associated with investing in PTRA over a specified time horizon. Remember, high PTRA's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to PTRA's market risk premium analysis include:
Beta (0.22) | Alpha 0.66 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
PTRA |
PTRA Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. PTRA market risk premium is the additional return an investor will receive from holding PTRA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PTRA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate PTRA's performance over market.| α | 0.66 | β | -0.22 |
PTRA Fundamentals Vs Peers
Comparing PTRA's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PTRA's direct or indirect competition across all of the common fundamentals between PTRA and the related equities. This way, we can detect undervalued stocks with similar characteristics as PTRA or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of PTRA's fundamental indicators could also be used in its relative valuation, which is a method of valuing PTRA by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PTRA to competition |
| Fundamentals | PTRA | Peer Average |
| Price To Earning | 0.74 X | 28.72 X |
| EBITDA | (206.96 M) | 3.9 B |
| Net Income | (237.95 M) | 570.98 M |
| Cash And Equivalents | 408.55 M | 2.7 B |
| Cash Per Share | 1.81 X | 5.01 X |
| Total Debt | 147.67 M | 5.32 B |
| Debt To Equity | 0.24 % | 48.70 % |
PTRA Opportunities
PTRA Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About PTRA Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PTRA or other pink sheets. Alpha measures the amount that position in PTRA has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
PTRA Upcoming Company Events
As portrayed in its financial statements, the presentation of PTRA's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PTRA's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of PTRA's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of PTRA. Please utilize our Beneish M Score to check the likelihood of PTRA's management manipulating its earnings.
| 1st of November 2023 Upcoming Quarterly Report | View | |
| 20th of March 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with PTRA
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in PTRA Pink Sheet
If you are still planning to invest in PTRA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PTRA's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |